Amifostine 200 mg/m2 three times weekly vs Amifostine 200 mg/m2 five times weekly
Nausea · Patients receiving radiotherapy on its own or in addition to chemotherapy to the head and neck region
Amifostine 200 mg/m2 three times weekly showed no clear difference in nausea (adverse effect) compared with amifostine 200 mg/m2 five times weekly; GRADE not reported.
1 finding from 1 review
- Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy 2017 · Cochrane All outcomesRR 0.64 [0.33, 1.25]1 study · 60 participantsGRADE not reported